X Henry Hu

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi request reprint Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate
    X Henry Hu
    Outcomes Research and Management, Merck and Co, Inc, West Point, PA 19486, USA
    J Clin Psychiatry 65:959-65. 2004
  2. doi request reprint EuroQol (EQ-5D) health utility scores for patients with migraine
    Ruifeng Xu
    Department of Health Economic Statistics, Merck Research Laboratories, North Wales, PA, USA
    Qual Life Res 20:601-8. 2011
  3. ncbi request reprint Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model
    William C Gerth
    Worldwide Outcomes Research, Merck and Co, Inc, Whitehouse Station, New Jersey 08889, USA
    J Occup Environ Med 46:48-54. 2004
  4. ncbi request reprint Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study
    Christopher F Bell
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    Clin Ther 28:872-80. 2006
  5. ncbi request reprint Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study
    Roger Cady
    Headache Care Center, Primary Care Network, Inc, Springfield, MO, USA
    Headache 44:900-7. 2004
  6. ncbi request reprint Treatment of migraine with rizatriptan: when to take the medication
    X Henry Hu
    Outcomes Research and Management, US Human Health, Merck and Co, Inc, West Point, PA, USA
    Headache 42:16-20. 2002
  7. ncbi request reprint Does early migraine treatment shorten time to headache peak and reduce its severity?
    X Henry Hu
    Global Outcomes Research, Global Human Health, Merck and Co, Inc, Whitehouse Station, NJ, USA
    Headache 48:914-20. 2008
  8. ncbi request reprint Acute migraine treatment with oral triptans and NSAIDs in a managed care population
    Daisy S Ng-Mak
    Outcomes Research and Management, Merck and Co, Inc, West Point, PA, USA
    Headache 48:1176-85. 2008
  9. ncbi request reprint Real-world experiences in migraine therapy with rizatriptan
    Dara Jamieson
    University of Pennsylvania, Philadelphia 19486, USA
    Headache 43:223-30. 2003
  10. ncbi request reprint Discontinuation of use and switching of antidepressants: influence of patient-physician communication
    Scott A Bull
    Division of Research, Kaiser Permanente Medical Care Program, 2000 Broadway, Oakland, CA 94612 2304, USA
    JAMA 288:1403-9. 2002

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate
    X Henry Hu
    Outcomes Research and Management, Merck and Co, Inc, West Point, PA 19486, USA
    J Clin Psychiatry 65:959-65. 2004
    ..Selective serotonin reuptake inhibitors (SSRIs) are widely used as the first-line treatment for depression. Information regarding their side effects is mostly based on controlled clinical trials...
  2. doi request reprint EuroQol (EQ-5D) health utility scores for patients with migraine
    Ruifeng Xu
    Department of Health Economic Statistics, Merck Research Laboratories, North Wales, PA, USA
    Qual Life Res 20:601-8. 2011
    ..We evaluated within-attack health utilities among acute migraine patients experiencing different grades of headache severity...
  3. ncbi request reprint Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model
    William C Gerth
    Worldwide Outcomes Research, Merck and Co, Inc, Whitehouse Station, New Jersey 08889, USA
    J Occup Environ Med 46:48-54. 2004
    ..S. company. There is a substantial productivity cost burden of migraine from a U.S. employer perspective. These productivity costs can be reduced significantly by treating migraine headaches with rizatriptan...
  4. ncbi request reprint Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study
    Christopher F Bell
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    Clin Ther 28:872-80. 2006
    ..Patients and physicians consider rapid onset of pain relief and pain freedom among the most important attributes of migraine therapy...
  5. ncbi request reprint Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study
    Roger Cady
    Headache Care Center, Primary Care Network, Inc, Springfield, MO, USA
    Headache 44:900-7. 2004
    ..To compare the effectiveness of rizatriptan to other non-triptan medications in the relief of migraine headache in usual care settings...
  6. ncbi request reprint Treatment of migraine with rizatriptan: when to take the medication
    X Henry Hu
    Outcomes Research and Management, US Human Health, Merck and Co, Inc, West Point, PA, USA
    Headache 42:16-20. 2002
    ..To assess, in the setting of routine clinical practice, rizatriptan's effectiveness in treating acute migraine at its onset versus in a later phase of the attack...
  7. ncbi request reprint Does early migraine treatment shorten time to headache peak and reduce its severity?
    X Henry Hu
    Global Outcomes Research, Global Human Health, Merck and Co, Inc, Whitehouse Station, NJ, USA
    Headache 48:914-20. 2008
    ..To explore whether early treatment would shorten the duration of headache from headache onset to its peak and reduce headache severity at peak...
  8. ncbi request reprint Acute migraine treatment with oral triptans and NSAIDs in a managed care population
    Daisy S Ng-Mak
    Outcomes Research and Management, Merck and Co, Inc, West Point, PA, USA
    Headache 48:1176-85. 2008
    ..To describe the use of oral triptans with or without nonsteroidal anti-inflammatory drugs (NSAIDs) for acute migraine treatment in a managed care population and its potential impact on functionality...
  9. ncbi request reprint Real-world experiences in migraine therapy with rizatriptan
    Dara Jamieson
    University of Pennsylvania, Philadelphia 19486, USA
    Headache 43:223-30. 2003
    ..To evaluate the effectiveness of rizatriptan for acute migraine treatment and patient satisfaction with the drug in usual clinical practice settings...
  10. ncbi request reprint Discontinuation of use and switching of antidepressants: influence of patient-physician communication
    Scott A Bull
    Division of Research, Kaiser Permanente Medical Care Program, 2000 Broadway, Oakland, CA 94612 2304, USA
    JAMA 288:1403-9. 2002
    ..Although current depression treatment guidelines recommend continuing antidepressant therapy for at least 4 to 9 months, many patients discontinue treatment prematurely, within 3 months...
  11. ncbi request reprint Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis
    Ashraf S Habib
    Duke University Medical Center, Durham, NC 27710, USA
    Curr Med Res Opin 22:1093-9. 2006
    ....